What we heard: Agile regulations for advanced therapeutic products and clinical trials

Description

The Health and Biosciences Sector Regulatory Review Roadmap outlined a number of regulatory modernization commitments. These included plans to modernize the regulations for clinical trials and advanced therapeutic products (ATPs).

Resources

Name Format Description Link
What we heard: Agile regulations for advanced therapeutic products and clinical trials HTML Open resource
What we heard: Agile regulations for advanced therapeutic products and clinical trials HTML Open resource

Tags

Topics

Categories